Deficits of [3H]D-aspartate binding to glutamate uptake sites in striatal and accumbens tissue in patients with schizophrenia

Neuroscience Letters

Volumn 232, Issue 1, 1997, Pages 13-16

  Iraide Aparicio Legarza, M ^a   Cutts, Andrew J ^a   Davis, Ben ^a   Reynolds, Gavin P ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

3H D aspartate binding; Antipsychotic drugs; Glutamate uptake sites; Postmortem human tissue; Schizophrenia

Indexed keywords

CLOZAPINE; GLUTAMATE RECEPTOR; GLUTAMIC ACID; HALOPERIDOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROLEPTIC AGENT; ASPARTIC ACID; DIAGNOSTIC AGENT; TRITIUM;

ARTICLE; BINDING SITE; BRAIN TISSUE; CONTROLLED STUDY; CORPUS STRIATUM; HUMAN; HUMAN TISSUE; INNERVATION; NEUROTRANSMISSION; NUCLEUS ACCUMBENS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCHIZOPHRENIA; AGED; ANIMAL; CHEMISTRY; FEMALE; FRONTAL LOBE; MALE; METABOLISM; MIDDLE AGED; RADIOASSAY; RAT; SYNAPTIC MEMBRANE; WISTAR RAT;

AGED; ANIMALS; ASPARTIC ACID; CORPUS STRIATUM; FEMALE; FRONTAL LOBE; GLUTAMIC ACID; HUMANS; MALE; MIDDLE AGED; NUCLEUS ACCUMBENS; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; RECEPTORS, GLUTAMATE; SCHIZOPHRENIA; SYNAPTIC MEMBRANES; TRITIUM;

EID: 0030612096     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00563-6     Document Type: Article

References (23)

1. Arriza, J.L., Fairman, W.A., Wadiche, J.I., Murdoch, G.H., Kavanaugh, M.P. and Amara, S.G., Functional comparison of three glutamate transporter subtypes cloned from human cortex, J. Neurosci., 14 (1994) 5559-5569.
2. Carlsson, M. and Carlsson, A., Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease, Trends Neurosci., 13 (1990) 272-276.
3. Cross, A.J., Slater, P. and Reynolds, G.P., Reduced high-affinity glutamate uptake sites in the brains of patients with Huntington's disease, Neurosci. Lett., 67 (1986) 198-202.
4. 3H]aspartate binding in cerebral cortex in patients with Alzheimer's and Parkinson's diseases, Neurosci. Lett., 79 (1987) 213-217.
5. Cutts, A.J. and Reynolds, G.P., D-Aspartate binding to the glutamate uptake site in human brain tissue-effects of leucotomy, J. Neural Transm., 94 (1993) 147-152.
6. Deakin, J.F.W., Slater, P., Simpson, M.D.C., Gilchrist, A.C., Skon, W.J., Royston, M.C., Reynolds, G.P. and Cross, C.J., Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia, J. Neurochem., 52 (1989) 1781-1786.
7. Fonnum, F., Storm-Mathisen, J. and Divac, I., Biochemical evidence for glutamate as a neurotransmitter in the cortico-striatal and corticothalamic fibres of rat brain, Neuroscience, 6 (1981) 863-875.
8. 3H]AMPA binding in postmortem human brain from psychotic subjects and controls: increases in caudate nucleus associated with suicide, Exp. Neurol., 121 (1993) 48-56.
9. Gundersen, V., Danbolt, N.C., Othersen, O.P. and Storm-Mathisen, J., Demonstration of glutamate/aspartate uptake activity in nerve endings by use of antibodies recognizing exogenous D-aspartate, Neuroscience, 57 (1993) 97-111.
10. Ishimaru, M., Kurumaji, A. and Toru, M., Increases in strychnine insensitive glycine binding sites in cerebral cortex of chronic schizophrenics: evidence for glutamate hypothesis, Biol. Psychiatry, 35 (1994) 84-95.
11. Javitt, D.C. and Zukin, S.R., Recent advances in the phencyclidine model of schizophrenia, Am. J. Psychiatry, 148 (1991) 1301-1308.
12. Kerwin, R., Patel, S. and Meldrum, B., Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem, Neuroscience, 39 (1990) 25-32.
13. Kim, J.S., Kornhuber, H.H., Schmid-Burgk, W. and Holzmuller, B., Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia, Neurosci. Lett., 20 (1980) 379-382.
14. Koek, W., Colpaert, F.C., Woods, J.H. and Kamenka, J.M., The phencyclidine (PCP) analog N-[1(2-benzo[b]thiphenyl-cyclohexyl]-piperidine shares cocaine-like but not other characteristic behavioural effects with PCP, ketamine and MK-801, J. Pharmacol. Exp. Ther., 250 (1989) 1019-1027.
15. 3H]MK-801 binding sites in post mortem brain regions of schizophrenic patients, J. Neural Transm., 77 (1989) 231-236.
16. 3H]Amino-3-hydroxy-5-methylisoxazole-4-propionic acid binding to human cerebral cortical membranes: minimal changes in postmortem brains of chronic schizophrenics, J. Neurochem., 59 (1992) 829-837.
17. Luisada, P.V., The phencyclidine psychosis. In R.C. Petersen and R.C. Stillman (Eds.), Phencyclidine (PCP) abuse, NIDA Research Monograph 21, US Government Printing Office, Washington DC, 1978, pp. 241-253.
18. Lund Karlsen, R., Neurotransmitters in the mammalian visual system. In F. Fonnum (Ed.), Amino Acids as Chemical Transmitters, Plenum Press, New York, 1978, pp. 241-256.
19. 3H]kainic acid binding in the prefrontal cortex in schizophrenia, Neurosci. Lett., 40 (1983) 245-250.
20. Perry, T.L., Normal cerebrospinal fluid and brain glutamate levels in schizophrenics do not support the hypothesis of glutamatergic neuronal dysfunction, Neurosci. Lett., 28 (1982) 81-85.
21. Sherman, A.D., Hegwood, T.S., Baruah, S. and Waziri, R., Deficient NMDA-mediated glutamate release from synaptosomes of schizophrenics, Biol. Psychiatry, 20 (1991) 1191-1198.
22. Slater, P., McConnell, S.W., Barson, A.J., Simpson, M.D.C. and Gilchrist, A., Age-related changes in binding to excitatory amino acid uptake site in temporal cortex of human brain, Brain Res., 65 (1992) 157-160.
23. Ulas, J., Monaghan, D.T. and Cotman, C.W., Kainate receptors in the rat hippocampus: a distribution and time course of changes in response to unilateral lesions of the entorhinal cortex, J. Neurosci., 10 (1990) 2352-2362.